The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
Open accessAbstract
In the RAS (renin–angiotensin system), Ang I (angiotensin I) is cleaved by ACE (angiotensin-converting enzyme) to form Ang II (angiotensin II), which has effects on blood pressure, fluid and electrolyte homoeostasis. We have examined the kinetics of angiotensin peptide cleavage by full-length human ACE, the separate N- and C-domains of ACE, the homologue of ACE, ACE2, and NEP (neprilysin). The activity of the enzyme preparations was determined by active-site titrations using competitive tight-binding inhibitors and fluorogenic substrates. Ang I was effectively cleaved by NEP to Ang (1–7) (kcat/Km of 6.2×105 M−1·s−1), but was a poor substrate for ACE2 (kcat/Km of 3.3×104 M−1·s−1). Ang (1–9) was a better substrate for NEP than ACE (kcat/Km of 3.7×105 M−1·s−1 compared with kcat/Km of 6.8×104 M−1·s−1). Ang II was cleaved efficiently by ACE2 to Ang (1–7) (kcat/Km of 2.2×106 M−1·s−1) and was cleaved by NEP (kcat/Km of 2.2×105 M−1·s−1) to several degradation products. In contrast with a previous report, Ang (1–7), like Ang I and Ang (1–9), was cleaved with a similar efficiency by both the N- and C-domains of ACE (kcat/Km of 3.6×105 M−1·s−1 compared with kcat/Km of 3.3×105 M−1·s−1). The two active sites of ACE exhibited negative co-operativity when either Ang I or Ang (1–7) was the substrate. In addition, a range of ACE inhibitors failed to inhibit ACE2. These kinetic data highlight that the flux of peptides through the RAS is complex, with the levels of ACE, ACE2 and NEP dictating whether vasoconstriction or vasodilation will predominate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Self-citationAngiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G., & Corvol, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9386 · Cited by 750
[17] The kinetics of reversible tight-binding inhibition
Williams, J. W., & Morrison, J. F. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63019-7 · Cited by 693
Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1
Erdös, E. G., & Skidgel, R. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.2.2521610 · Cited by 554
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
Turner, A. J., Isaac, R. E., & Coates, D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3<261::aid-bies1036>3.0.co;2-k · Cited by 452
Self-citationHubert, C., Houot, A. M., Corvol, P., & Soubrier, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98626-6 · Cited by 426
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 406
Self-citationThe two homologous domains of human angiotensin I-converting enzyme are both catalytically active
Wei, L., Alhenc-Gelas, F., Corvol, P., & Clauser, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31543-6 · Cited by 383
Zisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides
Gafford, J. T., Skidgel, R. A., Erdos, E. G., & Hersh, L. B. (1983) · Biochemistry · doi:10.1021/bi00282a035 · Cited by 285
The Role of ACE2 in Cardiovascular Physiology
Oudit, G. Y., Crackower, M. A., Backx, P. H., & Penninger, J. M. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00233-5 · Cited by 254
Deddish, P. A., Marcic, B., Jackman, H. L., Wang, H.-Z., Skidgel, R. A., & Erdös, E. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.912 · Cited by 244
Wei, L., Alhenc-Gelas, F., Soubrier, F., Michaud, A., Corvol, P., & Clauser, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67628-3 · Cited by 194
Guy, J. L., Jackson, R. M., Acharya, K. R., Sturrock, E. D., Hooper, N. M., & Turner, A. J. (2003) · Biochemistry · doi:10.1021/bi035268s · Cited by 189
Self-citationCell biology and genetics of angiotensin in cardiovascular disease
Dzau, V. (1994) · Journal of Hypertension - Supplement · doi:10.1097/00004872-199407030-00002 · Cited by 173
Georgiadis, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A., & Dive, V. (2003) · Circulation Research · doi:10.1161/01.res.0000081593.33848.fc · Cited by 157
Hooper, N. M., Keen, J. N., Pappin, D., & Turner, A. J. (1987) · Biochemical Journal · doi:10.1042/bj2470085 · Cited by 135
Self-citationKokkonen, J., Saarinen, J., & Kovanen, P. T. (1997) · Circulation · doi:10.1161/01.cir.95.6.1455 · Cited by 131
Vasopeptidase Inhibition: A Double-Edged Sword?
Campbell, D. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000054215.71691.16 · Cited by 116
Angiotensin-(1-7) Formation in the Intact Human Heart
Zisman, L. S., Meixell, G. E., Bristow, M. R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000094733.61689.d4 · Cited by 114
Yagil, Y., & Yagil, C. (2003) · Hypertension · doi:10.1161/01.hyp.0000063886.71596.c8 · Cited by 114
Angiotensin 1–9 and 1–7 release in human heart role of cathepsin, A
Jackman, H. L., Massad, M. G., Sekosan, M., Tan, F., Brovkovych, V., Marcic, B. M., & Erdös, E. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000017283.67962.02 · Cited by 110
Lawrence, A. C., Evin, G. M., Kladis, A., & Campbell, D. J. (1990) · Journal of Hypertension · doi:10.1097/00004872-199008000-00005 · Cited by 98
Essential Hypertension: Part II: Treatment
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.4.446 · Cited by 92
Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene
Soubrier, F., Hübert, C., Testut, P., Nadaud, S., Alhenc‐Gelas, F., & Corvol, P. L. (1993) · Journal of Hypertension · doi:10.1097/00004872-199305000-00001 · Cited by 84
Woodman, Z., Oppong, S. Y., Sarah, C. O. O. K., Hooper, N. M., Schwager, S. L. U., BRANDT, W. F., Ehlers, M. R., & Sturrock, E. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470711 · Cited by 76
Self-citationInhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
Hooper, N. M., Hryszko, J., Oppong, S. Y., & Turner, A. J. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.281 · Cited by 75
Self-citationBinevski, P. V., Sizova, E. A., Pozdnev, V. F., & Kost, O. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00825-1 · Cited by 60
Nakagomi, K., Yamada, R., Ebisu, H., Sadakane, Y., Akizawa, T., & Tanimura, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01163-7 · Cited by 59
Products of Angiotensin I Hydrolysis by Human Cardiac Enzymes Potentiate Bradykinin
Erdös, E. G., Jackman, H. L., Brovkovych, V. M., Tan, F., & Deddish, P. A. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2080 · Cited by 54
Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin
Rose, C., VOISIN, S., Claude, G. R. O. S., Schwartz, J.-C., & Ouimet, T. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630697 · Cited by 45
Bernstein, K. E. (2002) · Nature · doi:10.1038/417799a · Cited by 36
Effects of the N-Terminal Sequence of ACE on the Properties of Its C-Domain
Marcic, B. M., Deddish, P. A., Jackman, H. L., Erdös, E. G., & Tan, F. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.116-a · Cited by 30
The Renin-Angiotensin and Fibrinolytic Systems
Brown, N. J., & Vaughan, D. E. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(96)00091-6 · Cited by 28
Cited by
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Self-citationFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007621 · Cited by 1,428
RetractedThe ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Metadata
- Authors
- RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2004-09-24
- Volume
- 383
- Issue
- 1
- Pages
- 45-51
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2129053556
- Cited by
- 619
- References
- 39
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.